spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES

Micro dosing pumps in global use against COVID-19

From diagnostics and research to future vaccine production, micropumps can be used in the fight against COVID-19

(PresseBox) ( Schwerin, 24.06.20 ) Automated analysis devices are the essential basis for extensive test capacities for the corona virus. Through parallel and faster processes, automation significantly increases the number of tests, saves manpower and ensures process reliability. For sample preparation for SARS-CoV-2, a few microliters of a solution of chemicals and enzymes are dosed. Micro annular gear pumps of the low pressure series from HNP Mikrosysteme perform this demanding task with highest precision and process reliability. The minimum dosing quantity is 0.25 µl, the pumps have a very small footprint and can be easily integrated into control systems. Fully automated analysis devices can contain up to sixteen dosing pumps and can handle up to 4,000 samples in 24 hours. More>>

 
phone +49 385 52190-300
email info@hnp-mikrosysteme.de
web https://www.hnp-mikrosysteme.de/en/
email Bleicherufer 25 19053 Schwerin
 

DuPont Achieves Non-GMO Certification for SeaGel®, Reinforces Commitment to Sustainable, Quality Ingredients

DuPont Nutrition & Biosciences’ latest certification will allow manufacturers to add the iconic non-GMO Project verified seal to their end product, fostering brand transparency and consumer trust

More>>

 
web www.dupont.com/
 

Optimizing pharmaceutical processes

Future oriented pharmaceutical processes – a key to success

An increase in requirements from regulatory agencies around the world, combined with a growing demand for drugs in prefilled injections systems – a trend that industry experts have projected will continue – has led pharmaceutical and biotech supply chains to gain in significance. Well established and optimized processes are crucial for offering uninterrupted market supply. To satisfy its customers a CDMO must foster flexibility, efficiency and safety throughout the entire supply chain. The most important goal for all parties involved in the bio-pharma business is maximization of product quality where even small decisions can make a big difference. Future-oriented pharma processes can add value to any compound. More>>

 
phone +49 751 3700 0
email info@vetter-pharma.com
web www.vetter-pharma.com
email Eywiesenstraße 5, 88212 Ravensburg, Germany
 

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

- The biotech companies 3P Biopharmaceuticals and Toleranzia collaborate for that MG treatment - MG is an orphan disease which has a major unmet medical need and a large market potential - The drug candidate,TOL2, has already achieved several positive preclinical results More>>

 
phone +34 948 34 64 80
web www.3pbio.com/
email Polígono Mocholí, Plaza Cein, 1, 31110 Noáin, Navarra
 

Max Planck researchers feed Proteome AI with PharmaFluidics technology

Micro-chip based µPAC LC columns - key component in NATURE study doubling the universe of known proteins across all kingdoms of life.

PharmaFluidics NV, innovative player in the field of analytical chromatography, is excited to announce that researchers of Prof. Matthias Mann’s Group at the Max Planck Institute in Munich have integrated its unique high-resolution µPAC™ micro-Chip technology in their advanced proteomics workflow. More>>

 
phone +32 (0)9 241 56 57
web https://www.pharmafluidics.com/
email Technologiepark-Zwijnaarde 82 B-9052 Ghent (Zwijnaarde) BELGIUM
 

Leading pharma packaging companies commit to supply for Covid-19 fight

Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers

The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in. Also, the companies will make every effort to support the pharma industry’s’ priorities for overall medication supply in addition to Covid-19 drugs. Each of the three companies manufactures billions of type-1 borosilicate glass vials, the most proven and most widely available material used to store and deliver vaccines around the world. They are making the statement to provide confidence in the global pharmaceutical supply chain in times of uncertainty. More>>

 
phone +49-(0)211/61 81-00
email info@gerresheimer.com
web www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany
 

Kieran Coulton named new Chairman at ChargePoint Technology

ChargePoint Technology, specialists in contained and sterile powder transfer solutions has announced the appointment of Kieran Coulton as Chairman. Coulton is an accomplished leader in automation and manufacturing with a track record of 36 years in the industry. Having previously served as President Global Industry for GE Power Conversion, Kieran brings with him a wealth of experience and an ability to achieve excellent levels of business growth. More>>

 
phone +44 (0)151 728 4500
email info@thechargepoint.com
web www.thechargepoint.com/
email 80 Venture Point West, Evans Road, Liverpool, L24 9PB
 

SONOTEC® launches industrial clamp-on flow meter for plastic tubes and pipes for the use in hazardous areas of Zone 1 according to ATEX/IECEx

The new SEMIFLOW Ex1 Set opens a new product category of intrinsically safe ultrasonic flow sensors with control gear for non-contact liquid flow measurement on small and midsize rigid plastic tubes to ensure safe operation in hazardous areas. SEMIFLOW CO.66 PI Ex1 sensors are protected against explosion hazard by gases, vapors, and liquids according to the gas group IIB. The device protection level (EPL) is "Gb" for the use in Zone 1 according to ATEX/IECEx. More>>

 
email sonotec@sonotec.de
web https://www.sonotec.eu/
email SONOTEC Ultraschallsensorik Halle GmbH, Nauendorfer Str. 2, 06112 Halle (Saale), Germany
 

Leading pharma packaging companies commit to supply for Covid-19 fight

Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers

The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in. More>>

 
phone +39 049 9318111
web www.stevanatogroup.com
email Via Molinella, 17 - 35017 Piombino Dese - Padua
 

New Timestrip® Range Helps Fight Against Coronavirus

Novel Indicators Provide Essential Monitoring of Virus Specimens

11th June 2020 - Cambridge, UK – Timestrip®, the developer of smart indicator technology, has developed an important new range of indicators to help healthcare professionals meet WHO guidelines in the handling of virus specimens. The Timestrip Virus Specimen Transport (VST) series has been specially formulated to provide a clear indication when key temperature levels are exceeded. More>>

 
phone +44 (0)1223 911 863
email info@timestrip.com
web https://timestrip.com/?gclid=EAIaIQobChMI9vWNv7eG6gIVA-3tCh3DywcAEAAYASAAEgL8w_D_BwE
email Sheraton House Castle Park Cambridge CB3 0AX United Kingdom
 
spacer
News and Press Releases

Qatar Airways Becomes Largest Passenger and Cargo Airline Globally Despite the Illegal Blockade and COVID-19 Crisis

Airline’s resolve to continue operating and growing over the last three years in the face of the illegal blockade has enabled the airline to succeed during the COVID-19 crisis The Best Airline in the World has built strong levels of trust with passengers and governments around the world for continuing to operate to take people home and its leadership on safety measures Hamad International Airport, The Best Airport in the Middle East, leads the way with strong levels of customer service while implementing the latest technologies to optimise passenger and employee safety
More info >>


White Papers

Extractables and Leachables Testing: A Risk Based Approach

RSSL

Pharmaceutical products are in contact with many external components during both manufacture and usage and small amounts of chemicals may leach from these components with a potential health risk to the patient. Extractables and leachables (E&L) studies therefore play an important role in verifying the safety of a drug product over its lifetime. Regulatory organisations such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) are taking an increased interest in the interactions of various drug delivery devices, pharmaceutical product containers and medical devices with drug product and/or patient and this field is therefore growing in importance. Regulatory guidelines indicate that an extractables profile should be determined for all materials that contact the drug product. Once established, this profile can be used to determine whether any of these extractables are present as leachables within the product. If a leachable is detected, amounts can be determined using validated analytical methods, after which a biological risk can be established based on the exposure. This white paper will provide an overview of the processes used to determine extractables and leachables from plastics.
More info >>

Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement